Bioabsorbable Surgical Mesh Market Report 2026

Bioabsorbable Surgical Mesh Market Overview

• Bioabsorbable Surgical Mesh market size has reached to $1.25 billion in 2025 • Expected to grow to $1.88 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Increasing Number Of Surgical Procedures Is Driving The Growth Of The Market Due To Chronic Diseases • Market Trend: Surgical Innovations Drive Demand For Fully Absorbable Repair Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bioabsorbable Surgical Mesh Market?

Bioabsorbable surgical mesh refers to a medical implant made from materials that gradually break down and are absorbed by the body over time while providing temporary support to tissues during healing. These meshes are used in surgical procedures such as hernia repair or soft tissue reinforcement, reducing the need for permanent implants and minimizing long-term complications. The main product types of bioabsorbable surgical mesh are polymer-based mesh, composite mesh, and bioactive mesh. Polymer-based mesh refers to a type of bioabsorbable surgical mesh made from synthetic polymers such as polyglycolic acid (PGA), polylactic acid (PLA), or their copolymers. The multiple material types include polylactic acid, polyglycolic acid, polycaprolactone, composite materials, and natural polymers that are distributed through various distribution channels such as direct sales, online sales, and distributors and wholesalers and are used in various applications such as hernia repair, dural repair, urological surgery, cardiovascular surgery, orthopedic surgery, and others and cater to several end users such as hospitals, ambulatory surgical centers, specialty clinics, and research institutions.

What Is The Bioabsorbable Surgical Mesh Market Growth Forecast?

The bioabsorbable surgical mesh market size is expected to see strong growth in the next few years. It will grow to $1.88 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to advancements in bioabsorbable polymer materials, increasing demand for minimally invasive surgeries, rising use of bioactive and drug-eluting meshes, growing surgical volume in aging populations, expanding clinical adoption in specialty surgeries. Major trends in the forecast period include rising adoption of bioabsorbable mesh in hernia repair, growing preference for temporary implants over permanent mesh, increasing use of composite and bioactive mesh materials, focus on reducing post-surgical complications and infections, expansion of minimally invasive surgical procedures.

Global Bioabsorbable Surgical Mesh Market Segmentation

1) By Product Type: Polymer-Based Mesh, Composite Mesh, Bioactive Mesh 2) By Material Type: Polylactic Acid, Polyglycolic Acid, Polycaprolactone, Composite Materials, Natural Polymers 3) By Distribution Channel: Direct Sales, Online Sales, Distributors And Wholesalers 4) By Application: Hernia Repair, Dural Repair, Urological Surgery, Cardiovascular Surgery, Orthopedic Surgery, Other Applications 5) By End-Use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research Institutions Subsegments: 1) By Polymer-Based Mesh: Polyglycolic Acid (PGA) Mesh, Polylactic Acid (PLA) Mesh, Polycaprolactone (PCL) Mesh, Polydioxanone (PDO) Mesh 2) By Composite Mesh: Polymer-Collagen Composite Mesh, Polymer-Coated Composite Mesh, Synthetic-Biological Composite Mesh, Polymer-Hydrogel Composite Mesh 3) By Bioactive Mesh: Antimicrobial-Embedded Mesh, Growth Factor-Embedded Mesh, Drug-Eluting Mesh, Stem Cell-Seeded Mesh

What Is The Driver Of The Bioabsorbable Surgical Mesh Market?

The increasing number of surgical procedures is expected to propel the growth of the bioabsorbable surgical mesh market going forward. Surgical procedure refers to a medical intervention that involves the intentional, non-transient alteration of body structures, typically by cutting into tissue or repairing or removing a part of the body to treat, diagnose, or prevent disease, injury, or other medical conditions. The increasing number of surgical procedures is primarily due to the rising prevalence of chronic diseases such as cardiovascular diseases, cancer, and obesity-related conditions. Bioabsorbable surgical mesh helps surgical procedures by providing temporary support to healing tissues and gradually dissolving, which reduces the risk of long-term complications associated with permanent implants. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, there was a 5.5% rise in surgical procedures in 2023, with more than 15.8 million surgeries and 19.1 million non-surgical procedures performed globally. Therefore, the increasing number of surgical procedures is driving the growth of the bioabsorbable surgical mesh industry.

Key Players In The Global Bioabsorbable Surgical Mesh Market

Major companies operating in the bioabsorbable surgical mesh market are Johnson And Johnson, Medtronic plc, Integra LifeSciences Holdings Corporation, B Braun Melsungen AG, Advanced Medical Solutions Group plc, TELA Bio Inc, Kerecis Limited, W L Gore And Associates Inc, Assut Europe S p A, BioHealth Medical Technology Co Ltd, Aroa Biosurgery Limited, Cook Biotech Incorporated, Tissue Regenix Group plc, Aran Biomedical Teoranta, Deep Blue Medical Advances Inc, Meccellis Biotech, PrintBio Inc, Atrium Medical Corporation, Cousin Biotech, Surgical Mesh Technologies Inc, Gore Medical Bioabsorbables, MedSkin Solutions Dr Suwelack AG

Global Bioabsorbable Surgical Mesh Market Trends and Insights

Major companies operating in the bioabsorbable surgical mesh market are focusing on developing advanced products such as fully bioabsorbable pocket and strap designs to enhance ease of placement and fixation during hernia repair procedures. A fully bioabsorbable pocket and strap design integrates absorbable structural elements into the mesh, allowing for precise positioning and lateral fixation while eliminating the need for permanent implants. For instance, in April 2025, Becton, Dickinson and Company, a US-based medical device company, launched the Phasix ST Umbilical Hernia Patch. It is the first fully absorbable hernia patch specifically designed for umbilical hernias, featuring a pocket and strap configuration composed of poly-4-hydroxybutyrate (P4HB), a biologically derived polymer. This design mimics the handling and placement techniques of permanent mesh while being completely absorbed by the body over time. The patch also includes a hydrogel barrier based on Sepra Technology to minimize tissue adhesion. Available in multiple sizes, the product addresses a broad range of umbilical hernia defects and reflects growing market demand for non-permanent, patient-centric solutions in soft tissue reconstruction.

What Are Latest Mergers And Acquisitions In The Bioabsorbable Surgical Mesh Market?

In February 2024, RTI Surgical Inc., a US-based healthcare technology company, acquired Cook Biotech Incorporated for an undisclosed amount. With this acquisition, RTI Surgical aims to enhance its regenerative medicine contract development and manufacturing capabilities by integrating Cook Biotech’s porcine small intestinal submucosa (SIS) platform and biomaterials into its allograft and xenograft portfolio. Cook Biotech Incorporated is a US-based biotechnology company that specializes in developing and manufacturing SIS-derived extracellular matrix scaffolds and biomaterial products for a variety of clinical applications.

Regional Outlook

North America was the largest region in the bioabsorbable surgical mesh market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Bioabsorbable Surgical Mesh Market?

The bioabsorbable surgical mesh market consists of sales of collagen-based meshes, polyglycolic acid (PGA) meshes, polylactic acid (PLA) meshes, polycaprolactone (PCL) meshes, and composite bioabsorbable meshes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.